Contact this trialFirst, we need to learn more about you.
Radiation Therapy
Combined Radiation Therapy for Recurrent Prostate Cancer
Recruiting1 awardPhase 1 & 2
Maywood, Illinois
This trial tests a combination of internal and external radiation along with hormone therapy for men whose prostate cancer has returned after previous treatment. The treatment works by directly attacking cancer cells in the prostate and pelvis and reducing hormones that help cancer grow. Enzalutamide is approved by the FDA for the treatment of prostate cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service